<!DOCTYPE html>
<html lang='en'>

<head>
	<meta charset="utf-8">
	<title>Rinvoq (upadacitinib) FDA Approval History - Drugs.com</title>
			<meta name="description" content="FDA approval history for Rinvoq (upadacitinib) used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, Crohn&#039;s Disease, Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Giant Cell Arteritis. Supplied by AbbVie Inc.">
			<meta name="viewport" content="width=device-width, initial-scale=1">
	<meta name="referrer" content="origin-when-cross-origin">
			<meta name="robots" content="max-image-preview:large">
		<link rel='canonical' href='https://www.drugs.com/history/rinvoq.html'>
<link rel='search' type='application/opensearchdescription+xml' href='/opensearch.xml' title='Drugs.com'>
<meta property="fb:app_id" content="1470988726468809">
<meta property="article:author" content="https://www.facebook.com/Drugscom">
<meta property="article:publisher" content="https://www.facebook.com/Drugscom">
<meta property="og:title" content="Rinvoq (upadacitinib) FDA Approval History - Drugs.com">
<meta property="og:image" content="https://www.drugs.com/img/social/ddc-opengraph-logomark.png">
<meta property="og:site_name" content="Drugs.com">
<meta property="og:locale" content="en_US">
<meta property="og:type" content="article">
<meta property='og:description' content="FDA approval history for Rinvoq (upadacitinib) used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, Crohn&#039;s Disease, Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Giant Cell Arteritis. Supplied by AbbVie Inc.">
<meta property='og:url' content="https://www.drugs.com/history/rinvoq.html">
<!-- Twitter Summary Card -->
<meta name="twitter:card" content="summary">
<meta name="twitter:site" content="@drugscom">
		<link rel='preconnect' href='https://securepubads.g.doubleclick.net'>
<link rel='preconnect' href='https://tpc.googlesyndication.com'>
<link rel='preconnect' href='https://pagead2.googlesyndication.com'>
<link rel='preconnect' href='https://fundingchoicesmessages.google.com'>
<link rel='preconnect' href='https://micro.rubiconproject.com'>
	<!-- Favicons -->
	<link rel='manifest' href='/manifest.json'>
	<link rel='icon' type='image/png' sizes='32x32' href='/img/logo/favicon/ddc-icon-32x32.png'>
	<link rel='icon' type='image/png' sizes='16x16' href='/img/logo/favicon/ddc-icon-16x16.png'>
	<link rel='apple-touch-icon' sizes='180x180' href='/img/logo/favicon/apple-touch-icon-180x180.png'>
	<!-- CSS -->
	<style>body{margin:0;padding:0;}img{max-width:100%;height:auto;}.ddc-main-content{overflow-wrap:break-word;word-wrap:break-word;}.responsive-table-wrap{overflow-x:auto;}</style>
	<link rel='stylesheet' href='/bundle/css/ddc-pack-site.min.da177789.css'>
	<link rel='stylesheet' href='/bundle/css/component/component-tag.min.d24d3227.css'>
		<link rel='stylesheet' href='/bundle/css/support/support-print.min.f6e712c8.css' media='print'>
					<!-- Schema -->
	<script type='application/ld+json'>[{"@context":"https://schema.org/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":{"@type":"MedicalWebPage","@id":"https://www.drugs.com/"}},{"@type":"ListItem","position":2,"name":"FDA History","item":{"@type":"MedicalWebPage","@id":"https://www.drugs.com/history/"}},{"@type":"ListItem","position":3,"name":"Rinvoq","item":{"@type":"MedicalWebPage","@id":"https://www.drugs.com/history/rinvoq.html"}}]},{"@context":"https://schema.org/","@type":"MedicalWebPage","@id":"https://www.drugs.com/history/rinvoq.html","url":"https://www.drugs.com/history/rinvoq.html","name":"Rinvoq (upadacitinib) FDA Approval History","description":"FDA approval history for Rinvoq (upadacitinib) used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, Crohn&#039;s Disease, Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Giant Cell Arteritis. Supplied by AbbVie Inc.","audience":{"@type":"MedicalAudience","audienceType":"Patient"},"author":{"@type":"Organization","name":"Drugs.com","url":"https://www.drugs.com"},"isPartOf":{"@type":"WebSite","@id":"https://www.drugs.com/#website","name":"Drugs.com","url":"https://www.drugs.com"},"publisher":{"@type":"Organization","@id":"https://www.drugs.com/#organization","name":"Drugs.com","url":"https://www.drugs.com","logo":{"@type":"ImageObject","url":"https://www.drugs.com/img/logo/schema/drugscom-logomark-112x112.png","width":112,"height":112}},"image":{"@type":"ImageObject","contentUrl":"https://www.drugs.com/images/pills/custom/pill29542-2/rinvoq.png","url":"https://www.drugs.com/images/pills/custom/pill29542-2/rinvoq.png","caption":"Rinvoq (upadacitinib) 15 mg"},"reviewedBy":{"@type":"Person","name":"Judith Stewart","honorificSuffix":"BPharm"},"mainEntity":{"@type":"Drug","name":"Rinvoq","nonProprietaryName":"upadacitinib","prescriptionStatus":"Prescription Only","aggregateRating":{"@type":"AggregateRating","url":"https://www.drugs.com/comments/upadacitinib/rinvoq.html","reviewCount":265,"ratingCount":265,"ratingValue":"7.2","bestRating":10,"worstRating":1},"image":{"@type":"ImageObject","contentUrl":"https://www.drugs.com/images/pills/custom/pill29542-2/rinvoq.png","url":"https://www.drugs.com/images/pills/custom/pill29542-2/rinvoq.png","caption":"Rinvoq (upadacitinib) 15 mg"}},"dateModified":"2025-10-16"}]</script>
</head>

<body class='page-section-history page-doctype-content page-history-rinvoq-html'>


<a href='#content' class='ddc-skip-link'>Skip to main content</a>


<header id="header" class="ddc-header">
	<div class="ddc-header-container ddc-width-container">

		<div class="ddc-header-logo">
			<a href="//www.drugs.com/">
				<img class='logo' src='/img/logo/drugscom-logo.svg' alt="Drugs.com - Go to homepage" width='280' height='58' loading='lazy'>
			</a>
		</div>
					<form action='/search.php' method='get' class='ddc-header-search' role='search'>
				<div class="ddc-input-group-action">
					<label>
						<span class="ddc-form-label-placeholder">Search Drugs.com</span>
						<input type="text" id="livesearch-main" class="livesearch webkit-speech" name="searchterm" value="" placeholder="Search" maxlength="70" data-required="1" data-value="Rinvoq" data-autocomplete='main'>
					</label>

					<div class='ddc-header-search-close'>
						<button type='button' class='ddc-flex ddc-flex-items-center ddc-flex-justify-center' data-search-close>
							<span class="ddc-sr-only">Close</span>
							<svg class='ddc-icon ddc-icon-close' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M18 7.05 16.95 6 12 10.95 7.05 6 6 7.05 10.95 12 6 16.95 7.05 18 12 13.05 16.95 18 18 16.95 13.05 12 18 7.05Z' /></svg>						</button>
					</div>

					<div class="ddc-header-search-filter">
						<button type='button' data-value="search-alias=aps">
							<span data-search-select-value>All</span>
							<svg class='ddc-icon ddc-icon-directiondown' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M12 16.5 4.5 9l1.05-1.05L12 14.4l6.45-6.45L19.5 9 12 16.5Z' /></svg>						</button>

						<label>
							<span class="ddc-form-label-placeholder">Select the section you want to search in</span>
							<select name="sources[]" data-search-select>
								<option value=''>All</option>
<option value='consumer'>Consumer</option>
<option value='professional'>Professional</option>
<option value='drugimages'>Pill ID</option>
<option value='interactions'>Interactions</option>
<option value='newsandalerts'>News and alerts</option>
<option value='cg'>Care notes</option>
<option value='natural'>Natural products</option>
							</select>
						</label>
					</div>

					<button type='submit' class='ddc-btn ddc-header-search-button'>
						<span class='ddc-sr-only'>Search</span>
						<svg class='ddc-icon ddc-icon-search' width='24' height='24' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M17 15.4c2.4-3.1 2.4-7.4 0-10.5C14.1 1.1 8.7.4 4.9 3.3 1.1 6.2.4 11.6 3.3 15.4c2.9 3.8 8.3 4.5 12.1 1.6l4.8 4.8 1.6-1.6-4.8-4.8Zm-6.9 1.1c-3.5 0-6.4-2.9-6.4-6.4 0-3.5 2.9-6.4 6.4-6.4 3.5 0 6.4 2.9 6.4 6.4 0 3.5-2.9 6.4-6.4 6.4Z' /></svg>					</button>
				</div>

				<nav class="ddc-header-alpha-menu">
					Browse medications:
					<ul class="ddc-mg-0 ddc-list-unstyled">
						<li><a href='/alpha/a.html'>a</a></li>
<li><a href='/alpha/b.html'>b</a></li>
<li><a href='/alpha/c.html'>c</a></li>
<li><a href='/alpha/d.html'>d</a></li>
<li><a href='/alpha/e.html'>e</a></li>
<li><a href='/alpha/f.html'>f</a></li>
<li><a href='/alpha/g.html'>g</a></li>
<li><a href='/alpha/h.html'>h</a></li>
<li><a href='/alpha/i.html'>i</a></li>
<li><a href='/alpha/j.html'>j</a></li>
<li><a href='/alpha/k.html'>k</a></li>
<li><a href='/alpha/l.html'>l</a></li>
<li><a href='/alpha/m.html'>m</a></li>
<li><a href='/alpha/n.html'>n</a></li>
<li><a href='/alpha/o.html'>o</a></li>
<li><a href='/alpha/p.html'>p</a></li>
<li><a href='/alpha/q.html'>q</a></li>
<li><a href='/alpha/r.html'>r</a></li>
<li><a href='/alpha/s.html'>s</a></li>
<li><a href='/alpha/t.html'>t</a></li>
<li><a href='/alpha/u.html'>u</a></li>
<li><a href='/alpha/v.html'>v</a></li>
<li><a href='/alpha/w.html'>w</a></li>
<li><a href='/alpha/x.html'>x</a></li>
<li><a href='/alpha/y.html'>y</a></li>
<li><a href='/alpha/z.html'>z</a></li>
<li><a href='/alpha/0-9.html'>0-9</a></li>
					</ul>

					<a class='ddc-text-color-secondary' href="/search_advanced.html">Advanced Search</a>
				</nav>
			</form>
						<nav class='ddc-header-nav-account' aria-label="Account navigation">
									<a class='ddc-btn ddc-btn-empty ddc-btn-small ddc-btn-register' rel='nofollow' href='/account/register/'>Register</a>
					<a class='ddc-btn ddc-btn-secondary ddc-btn-small' rel='nofollow' href='/account/login/'>Sign in</a>
								</nav>
					<div class='ddc-header-nav-controls'>
			<button data-nav-toggle>
				<span class='ddc-sr-only'>Site navigation</span>
				<svg class='ddc-icon ddc-icon-menu' width='28' height='28' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M22.5 7.125h-21v-2.25h21v2.25Zm0 6h-21v-2.25h21v2.25Zm-21 6h21v-2.25h-21v2.25Z' /></svg>				<svg class='ddc-icon ddc-icon-close' width='28' height='28' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M18 7.05 16.95 6 12 10.95 7.05 6 6 7.05 10.95 12 6 16.95 7.05 18 12 13.05 16.95 18 18 16.95 13.05 12 18 7.05Z' /></svg>			</button>
		</div>
	</div>

	<div class='ddc-width-container'>
		<nav class='ddc-header-nav' aria-label="Main navigation">
		<ul>
		
<li class='ddc-header-nav-item ddc-header-nav-item-plus'>
	<a href='/account/plan/?launch=ddc-tier-1'>
		<div class='ddc-flex ddc-flex-column ddc-flex-gap-1'>
			<b>Upgrade to a Plus Plan</b>
			<span class='ddc-display-block ddc-text-color-secondary ddc-text-size-small ddc-text-weight-normal'>Remove ads and unlock more features.</span>
		</div>
		<svg class='ddc-icon ddc-icon-plusexpressive' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='m15.583 16.804-1.72.297a1.04 1.04 0 0 0 0 2.048l1.73.298c.491.085.875.469.96.96l.279 1.616c.097.565.595.977 1.168.977s1.071-.412 1.168-.977l.28-1.616c.084-.491.468-.875.959-.96l1.73-.298a1.039 1.039 0 0 0 0-2.048l-1.72-.297a1.176 1.176 0 0 1-.962-.972l-.296-1.845a1.173 1.173 0 0 0-2.318 0l-.296 1.845c-.08.496-.466.887-.962.972ZM5.05 7.101l-2.67.46a1.662 1.662 0 0 0 0 3.277l2.688.463a2 2 0 0 1 1.63 1.631l.43 2.491a1.9 1.9 0 0 0 3.744 0l.43-2.49a2 2 0 0 1 1.63-1.632l2.688-.463a1.662 1.662 0 0 0 0-3.277l-2.67-.46a2 2 0 0 1-1.635-1.654l-.461-2.867a1.878 1.878 0 0 0-3.708 0l-.46 2.867A2 2 0 0 1 5.05 7.101Z' /></svg>	</a>
</li>
					<li class='ddc-header-nav-item ddc-header-nav-item-account'>
				<a href='/account/login/' rel='nofollow'>Account</a>
				<ul>
					<li><a href='/account/login/' rel='nofollow'>Sign in</a></li>
					<li><a href='/account/register/' rel='nofollow'>Create an account</a></li>
				</ul>
			</li>
					<li class='ddc-header-nav-item'><a href='/drug_information.html'>Drugs A-Z</a></li>
		<li class='ddc-header-nav-item'><a href='/pill_identification.html'>Pill Identifier</a></li>
		<li class='ddc-header-nav-item'><a href='/drug_interactions.html'>Drug Interaction Checker</a></li>
		<li class='ddc-header-nav-item'><a href='/compare/'>Compare Drugs</a></li>
		<li class='ddc-header-nav-item'><a href='/news.html'>News</a></li>
		<li class='ddc-header-nav-item'><a href='/professionals.html'>Pro Edition</a></li>
		<li class='ddc-header-nav-item'><a class='ddc-link-forward' href='/sitemap.html'>More<span class='ddc-sr-only'> Resources</span></a></li>
		<li class='ddc-header-nav-item'><a href='/support/'>Help &amp; Support</a></li>
	</ul>
</nav>
	</div>
</header>


<div class='display-ad-leaderboard'>
<div id='display-ad-1' class='display-ad display-ad-static display-ad-728x90'></div>	<button type='button' data-toggle-class='.display-ad-leaderboard'>
		<span class='ddc-sr-only'>Close</span>
		<svg class='ddc-icon ddc-icon-close' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M18 7.05 16.95 6 12 10.95 7.05 6 6 7.05 10.95 12 6 16.95 7.05 18 12 13.05 16.95 18 18 16.95 13.05 12 18 7.05Z' /></svg>	</button>
</div>

<main id='container' class='ddc-main-container ddc-width-container' data-ad-container>
	<div id='content' class='ddc-main-content' data-ad-injection>
		
		<div class='ddc-main-content-head'>
<nav class='ddc-breadcrumb' aria-label='Breadcrumbs'>
<ol class='ddc-breadcrumb-3'>
<li><a class='ddc-breadcrumb-item' href='/'>Home</a></li>
<li><a class='ddc-breadcrumb-item' href='/history/'>FDA History</a></li>
<li aria-current='page'><span class='ddc-breadcrumb-item'>Rinvoq</span></li>
</ol>
</nav>
<div class='ddc-page-header-options ddc-flex ddc-flex-gap-3 noprint'>
<button type='button' class='ddc-flex ddc-flex-items-center ddc-flex-gap-1' data-action='print'>
<svg class='ddc-icon ddc-icon-print' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M21 6.75h-2.25v-4.5H5.25v4.5H3a1.5 1.5 0 0 0-1.5 1.5v7.5a1.5 1.5 0 0 0 1.5 1.5h2.25v4.5h13.5v-4.5H21a1.5 1.5 0 0 0 1.5-1.5v-7.5a1.5 1.5 0 0 0-1.5-1.5Zm-14.25-3h10.5v3H6.75v-3Zm10.5 16.5H6.75v-7.5h10.5v7.5Zm3.75-4.5h-2.25v-4.5H5.25v4.5H3v-7.5h18v7.5Z' /></svg>Print
</button>
<button type='button' class='ddc-flex ddc-flex-items-center ddc-flex-gap-1' data-action='share-mednotes' data-source='header'>
<svg class='ddc-icon ddc-icon-docsave' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M4.5 4.5A1.5 1.5 0 0 1 6 3h12a1.5 1.5 0 0 1 1.5 1.5V12H18V4.5H6V21h6v1.5H6A1.5 1.5 0 0 1 4.5 21V4.5Zm18 13.5h-3v-3H18v3h-3v1.5h3v3h1.5v-3h3V18ZM8.25 6.75h7.5v1.5h-7.5v-1.5Zm7.5 3.75h-7.5V12h7.5v-1.5Zm-7.5 3.75H12v1.5H8.25v-1.5Z' /></svg>Save
</button>
</div>
</div>
		
<!-- Content start -->
<h1>Rinvoq FDA Approval History</h1>

<p class='ddc-reviewed-by'><span>Last updated by <a class='ddc-reviewed-by-link' href='/support/editorial_policy.html#judith-stewart-bpharm'>Judith Stewart, BPharm</a> on Oct 16, 2025.</span></p><p class='drug-subtitle'><b>FDA Approved:</b> Yes (First approved August 16, 2019)<br>
<b>Brand name:</b> Rinvoq<br>
<b>Generic name:</b> upadacitinib<br>
<b>Dosage form:</b> Extended-Release Tablets<br>
<b>Company:</b> <a href="/manufacturer/abbvie-inc-482.html">AbbVie Inc.</a><br>
<b>Treatment for:</b> <a href="/condition/rheumatoid-arthritis.html">Rheumatoid Arthritis</a>, <a href="/condition/psoriatic-arthritis.html">Psoriatic Arthritis</a>, <a href="/condition/atopic-dermatitis.html">Atopic Dermatitis</a>, <a href="/condition/ulcerative-colitis.html">Ulcerative Colitis</a>, <a href="/condition/crohn-s-disease.html">Crohn's Disease</a>, <a href="/condition/ankylosing-spondylitis.html">Ankylosing Spondylitis</a>, <a href="/condition/non-radiographic-axial-spondyloarthritis.html">Non-Radiographic Axial Spondyloarthritis</a>, <a href="/condition/polyarticular-juvenile-idiopathic-arthritis.html">Polyarticular Juvenile Idiopathic Arthritis</a>, <a href="/condition/giant-cell-arteritis.html">Giant Cell Arteritis</a><br>
</p><p><a href="/rinvoq.html"><b>Rinvoq</b></a> (upadacitinib) is a Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohnâ€™s disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis, and giant cell arteritis.</p><ul>
<li>Rinvoq works by blocking the activity of Janus kinase enzymes in the JAK-STAT signaling pathway, an intracellular pathway that plays a major role in the release of the pro-inflammatory cytokines that stimulate inflammation in rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn&rsquo;s disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and giant cell arteritis.</li>
<li><strong>Rinvoq</strong> is an extended-release tablet formulation of upadacitinib indicated for the treatment of:<br />- adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers.<br />- patients 2 years of age and older with active psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.<br />- adults and pediatric patients 12 years of age and older with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies are inadvisable.<br />- adults with moderately to severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers. If TNF blockers are clinically inadvisable, patients should have received at least one approved systemic therapy prior to use of Rinvoq.<br />- adults with moderately to severely active Crohn&rsquo;s disease who have had an inadequate response or intolerance to one or more TNF blockers. If TNF blockers are clinically inadvisable, patients should have received at least one approved systemic therapy prior to use of Rinvoq.<br />- adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more TNF blockers.<br />- adults with active nonradiographic axial spondyloarthritis with objective signs of inflammation who have had an inadequate response or intolerance to TNF blocker therapy.<br />- patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.<br />- adults with giant cell arteritis.</li>
<li><strong>Rinvoq LQ </strong>is an oral solution formulation of upadacitinib indicated for the treatment of:<br />- patients 2 years of age and older with active psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.<br />- patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.</li>
<li>Rinvoq LQ oral solution is not substitutable with Rinvoq extended-release tablets. Changes between Rinvoq LQ oral solution and Rinvoq extended-release tablets should be made by the healthcare provider.</li>
<li>Rinvoq extended-release tablets are administered orally once daily. Rinvoq LQ oral solution is administered orally twice daily.</li>
<li>Rinvoq carries a boxed warning for the risk of serious infections, an increased rate of all-cause mortality, malignancies, adverse cardiovascular events, and thrombosis. Warnings and precautions associated with Rinvoq include serious infections, hypersensitivity reactions, gastrointestinal (GI) perforations, laboratory abnormalities, and embryo-fetal toxicity.</li>
<li>Adverse reactions (&ge; 1%) in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis patients include upper respiratory tract infections, herpes zoster, herpes simplex, bronchitis, nausea, cough, pyrexia, acne, and headache.<br />Adverse reactions (&ge; 1%) in atopic dermatitis patients include upper respiratory tract infections, acne, herpes simplex, headache, increased blood creatine phosphokinase, cough, hypersensitivity, folliculitis, nausea, abdominal pain, pyrexia, increased weight, herpes zoster, influenza, fatigue, neutropenia, myalgia, and influenza like illness.<br />Adverse reactions (&ge; 5%) in ulcerative colitis patients include upper respiratory tract infections, increased blood creatine phosphokinase, acne, neutropenia, elevated liver enzymes, pyrexia, and rash.<br />Adverse reactions (&ge; 5%) in Crohn&rsquo;s disease patients include upper respiratory tract infections, anemia, pyrexia, acne, herpes zoster, and headache.<br />Adverse reactions ((&ge; 5%) in giant cell arteritis patients include upper respiratory tract infections, headache, fatigue, peripheral edema, cough, anemia, rash, herpes zoster, and nausea.</li>
</ul><div class='ddc-mgt-3 ddc-mgb-3'>
	<a href='https://www.google.com/preferences/source?q=https://www.drugs.com'>
		<span class='ddc-sr-only'>Add as a preferred source on Google</span>
		<img src='/img/banners/google-preferred-news-source-badge.png' style='width:auto;height:56px;' width='338' height='107' alt='Google preffered source badge' loading='lazy'>
	</a>
</div>
<h2>Development timeline for Rinvoq</h2>
<table class='ddc-table-secondary'>
<thead><tr><th scope='col'>Date</th><th scope='col'>Article</th></tr></thead><tbody><tr><td class='ddc-text-nowrap'>Oct 13, 2025</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/fda-approves-updated-indication-statement-rinvoq-upadacitinib-inflammatory-bowel-6639.html'>FDA Approves Updated Indication Statement for Rinvoq (upadacitinib) for the Treatment of Inflammatory Bowel Disease</a></td></tr><tr><td class='ddc-text-nowrap'>Apr 29, 2025</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/rinvoq-upadacitinib-receives-u-s-fda-approval-giant-cell-arteritis-gca-6510.html'>Rinvoq (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)</a></td></tr><tr><td class='ddc-text-nowrap'>Jun &nbsp;4, 2024</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/rinvoq-rinvoq-lq-upadacitinib-now-available-pediatric-patients-two-years-older-polyarticular-6641.html'>Rinvoq/Rinvoq LQ (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>May 19, 2023</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/u-s-fda-approves-rinvoq-upadacitinib-once-daily-pill-moderately-severely-active-crohn-s-adults-6018.html'>U.S. FDA Approves Rinvoq (upadacitinib) as a Once-Daily Pill for Moderately to Severely Active Crohn's Disease in Adults</a></td></tr><tr><td class='ddc-text-nowrap'>Oct 21, 2022</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/rinvoq-upadacitinib-receives-fda-approval-adults-active-non-radiographic-axial-spondyloarthritis-5918.html'>Rinvoq (upadacitinib) Receives FDA Approval for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Jul 27, 2022</td><td><a href="/clinical_trials/abbvie-submits-regulatory-applications-fda-ema-rinvoq-crohn-s-20282.html">AbbVie Submits Regulatory Applications to FDA and EMA for Rinvoq in Crohn's Disease</a></td></tr><tr><td class='ddc-text-nowrap'>Apr 29, 2022</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/rinvoq-upadacitinib-approved-u-s-fda-oral-adults-active-ankylosing-spondylitis-5828.html'>Rinvoq (upadacitinib) Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis</a></td></tr><tr><td class='ddc-text-nowrap'>Mar 16, 2022</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/rinvoq-upadacitinib-receives-fda-approval-adults-moderately-severely-active-ulcerative-colitis-5800.html'>Rinvoq (upadacitinib) Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis</a></td></tr><tr><td class='ddc-text-nowrap'>Jan 14, 2022</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/u-s-fda-approves-rinvoq-upadacitinib-adults-children-12-years-older-refractory-moderate-severe-5767.html'>U.S. FDA Approves Rinvoq (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis</a></td></tr><tr><td class='ddc-text-nowrap'>Dec 14, 2021</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/rinvoq-upadacitinib-receives-u-s-fda-approval-active-psoriatic-arthritis-5736.html'>Rinvoq (upadacitinib) Receives U.S. FDA Approval for Active Psoriatic Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Aug 16, 2019</td><td><span class='ddc-tag ddc-tag-success' aria-label="%s">Approval</span>&nbsp;<a href='/newdrugs/fda-approves-rinvoq-upadacitinib-oral-jak-inhibitor-moderate-severe-rheumatoid-arthritis-5033.html'>FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Jun 12, 2019</td><td><a href="/clinical_trials/new-long-term-data-upadacitinib-phase-3-studies-rheumatoid-arthritis-including-results-clinical-18190.html">New Long-Term Data from Upadacitinib Phase 3 Studies in Rheumatoid Arthritis Including Results on Clinical Remission at 48 Weeks Presented at EULAR</a></td></tr><tr><td class='ddc-text-nowrap'>Feb 19, 2019</td><td><a href="/nda/upadacitinib_190219.html">AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Dec 20, 2018</td><td><a href="/nda/upadacitinib_181220.html">AbbVie Submits New Drug Application to U.S. FDA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Oct 23, 2018</td><td><a href="/clinical_trials/abbvie-s-upadacitinib-shows-significant-improvements-physical-function-pain-quality-monotherapy-17979.html">AbbVie's Upadacitinib Shows Significant Improvements in Physical Function, Pain and Quality of Life as a Monotherapy in Patients with Rheumatoid Arthritis in Phase 3 Patient-Reported Outcomes Data</a></td></tr><tr><td class='ddc-text-nowrap'>Oct 22, 2018</td><td><a href="/clinical_trials/positive-phase-2b-data-abbvie-s-upadacitinib-show-significant-induction-clinical-remission-response-17978.html">Positive Phase 2b Data for AbbVie's Upadacitinib Show Significant Induction of Clinical Remission and Response in Patients with Ulcerative Colitis</a></td></tr><tr><td class='ddc-text-nowrap'>Sep 13, 2018</td><td><a href="/clinical_trials/abbvie-presents-upadacitinib-longer-term-32-week-patient-reported-outcomes-data-phase-2b-atopic-17924.html">AbbVie Presents Upadacitinib Longer-Term (32-Week) and Patient-Reported Outcomes Data from Phase 2b Atopic Dermatitis Study at 27th European Academy of Dermatology and Venereology (EADV) Congress</a></td></tr><tr><td class='ddc-text-nowrap'>Jun &nbsp;5, 2018</td><td><a href="/clinical_trials/upadacitinib-monotherapy-meets-all-primary-ranked-secondary-endpoints-versus-methotrexate-phase-3-17824.html">Upadacitinib Monotherapy Meets All Primary and Ranked Secondary Endpoints Versus Methotrexate in a Phase 3 Study in Rheumatoid Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Apr &nbsp;9, 2018</td><td><a href="/clinical_trials/upadacitinib-meets-all-primary-ranked-secondary-endpoints-including-superiority-versus-adalimumab-17784.html">Upadacitinib Meets All Primary and Ranked Secondary Endpoints Including Superiority Versus Adalimumab in Phase 3 Study in Rheumatoid Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Feb 16, 2018</td><td><a href="/clinical_trials/abbvie-announces-new-phase-2-data-upadacitinib-showing-clinical-endoscopic-outcomes-crohn-s-52-weeks-17722.html">AbbVie Announces New Phase 2 Data for Upadacitinib Showing Clinical and Endoscopic Outcomes in Crohn's Disease at 52 Weeks</a></td></tr><tr><td class='ddc-text-nowrap'>Jan &nbsp;8, 2018</td><td><a href="/clinical_trials/abbvie-s-upadacitinib-granted-breakthrough-therapy-designation-u-s-food-administration-atopic-17695.html">AbbVie's Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis</a></td></tr><tr><td class='ddc-text-nowrap'>Dec 20, 2017</td><td><a href="/clinical_trials/abbvie-s-upadacitinib-shows-positive-results-monotherapy-phase-3-rheumatoid-arthritis-study-meeting-17694.html">AbbVie's Upadacitinib Shows Positive Results as Monotherapy in Phase 3 Rheumatoid Arthritis Study, Meeting All Primary and Key Secondary Endpoints</a></td></tr><tr><td class='ddc-text-nowrap'>Sep 11, 2017</td><td><a href="/clinical_trials/abbvie-s-upadacitinib-abt-494-meets-all-primary-ranked-secondary-endpoints-second-phase-3-study-17607.html">AbbVie's Upadacitinib (ABT-494) Meets All Primary and Ranked Secondary Endpoints in Second Phase 3 Study in Rheumatoid Arthritis</a></td></tr><tr><td class='ddc-text-nowrap'>Sep &nbsp;7, 2017</td><td><a href="/clinical_trials/abbvie-s-upadacitinib-abt-494-meets-primary-endpoint-phase-2b-study-atopic-dermatitis-17606.html">AbbVie's Upadacitinib (ABT-494) Meets Primary Endpoint in Phase 2b Study in Atopic Dermatitis</a></td></tr><tr><td class='ddc-text-nowrap'>Jun &nbsp;7, 2017</td><td><a href="/clinical_trials/abbvie-s-upadacitinib-abt-494-meets-all-primary-ranked-secondary-endpoints-phase-3-study-rheumatoid-17521.html">AbbVie's Upadacitinib (ABT-494) Meets All Primary and Ranked Secondary Endpoints in Phase 3 Study in Rheumatoid Arthritis</a></td></tr></tbody>
</table>
<div class='see-also'><h2>See also</h2><p><a href="/rinvoq.html">Rinvoq (upadacitinib) Consumer information</a></p></div>
<h2>Further information</h2><p class='ddc-disclaimer'>Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p class='ddc-disclaimer-link'><a href='/support/disclaimer.html'>Medical Disclaimer</a></p>

<!-- Content end -->

	</div>

	
<!-- Sidebar start -->
<div id='sidebar' class='ddc-main-sidebar'>
	<div class='ddc-sidebox ddc-status-info'>
		<b class='ddc-status-info-title'>Drug Status</b>
		<div class='ddc-box'>
				<div class='ddc-status-info-item ddc-flex'>
	<div class='ddc-status-info-item-heading'>
		
			<b>Availability</b>
		
		<span class='ddc-status-info-item-subtitle ddc-display-block'>Prescription only</span>
		<span class='ddc-status-icon drugInfoRx1'>Rx</span>
	</div>
</div><div class='ddc-status-info-item ddc-flex'>
	<div class='ddc-status-info-item-heading'>
		<a href='/pregnancy/upadacitinib.html'>
			<b>Pregnancy &amp; Lactation</b>
		</a>
		<span class='ddc-status-info-item-subtitle ddc-display-block'>Risk data available</span>
		<span class='ddc-status-icon drugInfoPregMultiple'><svg class='ddc-icon ddc-icon-pregnancy' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M10.62 7.03c.38-1.4 2.43-2.17 3.3-1.27.2.2.33.5.48.98l.11.36.12.42.06.23.29 1.13.09.34.02.08c.08.17.48.42 1.19.69l.98.34.26.1.3.14a2.7 2.7 0 011.42 2.99c-.2 1.2-.9 2.25-2.24 3.68a8.56 8.56 0 01-5.62 2.44c-2.35.17-4.48-1.02-5.23-2.63a5.89 5.89 0 01-.24-.6l-.11-.35-.12-.42-.26-.94-.09-.32-.08-.27-.08-.2-.07-.16a.57.57 0 00-.08-.14H5l-.1.01-.15.02-.62.13c-.35.06-.56.07-.83 0-.87-.18-1.3-.67-1.5-1.45a2.28 2.28 0 011-2.36l.16-.1.1-.06.18-.1.22-.1.24-.11.45-.18.36-.14.93-.34c1.67-.6 2.7-.28 3.44.85a3 3 0 01.51 1.27l.07.46.04.18c.07.33.37.5.8.5.2 0 .77-.24 1.14-.44l.07-.05-.1-.15-.17-.27-.07-.12a1 1 0 01-.06-.19l-.02-.08-.24-.9-.1-.48c-.06-.26-.1-.5-.14-.74-.08-.59-.1-1.1-.02-1.54zm2.24-.14h-.02c-.09 0-.19.03-.28.07-.28.1-.46.29-.5.47-.04.26-.03.63.03 1.07.05.3.11.63.2.98l.27 1.05c0-.01 0-.01 0 0l.17.23.17.26c.08.14.14.26.19.4a1 1 0 01-.17 1.01c-.42.5-1.88 1.2-2.62 1.2-1.06 0-2.03-.56-2.27-1.7a8.8 8.8 0 01-.08-.41l-.07-.43-.02-.1a1.6 1.6 0 00-.23-.44c-.36-.54-.65-.63-1.69-.26l-.66.24-.66.25-.37.15-.2.08-.16.09-.14.08-.2.12c-.2.14-.34.51-.3.69.08.27.1.3.36.36h.16l.08-.02.54-.1c.78-.15 1.26-.1 1.73.4.26.28.43.63.62 1.26l.12.41.31 1.16.1.33.1.28.04.13.1.22c.48 1.03 2.02 1.9 3.76 1.77a7.08 7.08 0 004.63-1.97c1.15-1.23 1.72-2.1 1.86-2.92.12-.68-.12-1.13-.64-1.4a.6.6 0 00-.04-.03l-.16-.06-.35-.13-.8-.28-.24-.1c-.96-.37-1.55-.78-1.82-1.43l-.03-.07-.05-.17-.06-.22-.44-1.7-.1-.35-.1-.27-.07-.2zM19 3.25a3.25 3.25 0 110 6.5 3.25 3.25 0 010-6.5zm0 1.5a1.75 1.75 0 100 3.5 1.75 1.75 0 000-3.5z' /></svg></span>
	</div>
</div><details class='ddc-accordion ddc-status-info-accordion'>
	<summary data-type='csa' data-target='accordion-content-2' data-box-info-module='drug' data-id='N' data-ddc_id='4084' data-brand_name_id='0'>
		
			<b>CSA Schedule*</b>
			<span class='ddc-status-info-item-subtitle ddc-display-block'>Not a controlled drug</span>
			<span class='ddc-status-icon drugInfoCSAN'>N/A</span>
			<svg class='ddc-icon ddc-icon-accordionexpand' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M12 16.5 4.5 9l1.05-1.05L12 14.4l6.45-6.45L19.5 9 12 16.5Z' /></svg>
		
	</summary>
	<div id='accordion-content-2' class='ddc-status-info-content ddc-text-wordbreak ddc-text-size-small'>
	<div class='ddc-text-color-secondary' aria-live='polite'>
		<p>Loading...</p>
	</div>
</div>
</details><details class='ddc-accordion ddc-status-info-accordion'>
	<summary data-type='approval' data-target='accordion-content-3' data-box-info-module='drug' data-id='0' data-ddc_id='4084' data-brand_name_id='19183'>
		
			<b>Approval History</b>
			<span class='ddc-status-info-item-subtitle ddc-display-block'>Drug history at FDA</span>
			<span class='ddc-status-icon drugInfoDateCal'><svg class='ddc-icon ddc-icon-history' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M19.5,3h-3V1.5h-1.5v1.5h-6V1.5h-1.5v1.5h-3c-.8,0-1.5,.7-1.5,1.5v15c0,.8,.7,1.5,1.5,1.5h15c.8,0,1.5-.7,1.5-1.5V4.5c0-.8-.7-1.5-1.5-1.5Zm0,16.5H4.5V9h15v10.5Zm0-12H4.5v-3h3v1.5h1.5v-1.5h6v1.5h1.5v-1.5h3v3Z' /></svg></span>
			<svg class='ddc-icon ddc-icon-accordionexpand' width='20' height='20' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M12 16.5 4.5 9l1.05-1.05L12 14.4l6.45-6.45L19.5 9 12 16.5Z' /></svg>
		
	</summary>
	<div id='accordion-content-3' class='ddc-status-info-content ddc-text-wordbreak ddc-text-size-small'>
	<div class='ddc-text-color-secondary' aria-live='polite'>
		<p>Loading...</p>
	</div>
</div>
</details>		</div>
	</div>
	<div class='ddc-sidebox ddc-sidebox-ad-300'>
	<div id='display-ad-2' class='display-ad display-ad-static display-ad-300x250'></div></div>

<div class='ddc-sidebox ddc-sidebox-subscribe ddc-box'>
	<div class='ddc-sidebox-content'>
		<form action='/newsletters/' method='post'>
			<input type='hidden' name='source' value='sidebox'>
			<fieldset class='ddc-mgb-1'>
				<legend class='ddc-sidebox-title'>Subscribe to our newsletters</legend>

									<input type='hidden' name='ddc_id' value='4084'>
					<input type='hidden' name='brand_name_id' value='19183'>

					<div class='ddc-form-check'>
						<label>
							<input type='checkbox' name='newsletters[]' value='medication' checked='checked'>
							<span>News &amp; warnings for this drug</span>
						</label>
					</div>
					
				<div class='ddc-form-check'>
					<label>
						<input type='checkbox' name='newsletters[]' value='monthly'>
						<span>Monthly newsletter</span>
					</label>
				</div>
				<div class='ddc-form-check'>
					<label>
						<input type='checkbox' name='newsletters[]' value='daily'>
						<span>Daily MedNews</span>
					</label>
				</div>
				<div class='ddc-form-check'>
					<label>
						<input type='checkbox' name='newsletters[]' value='fda_alerts'>
						<span>FDA safety alerts</span>
					</label>
				</div>
			</fieldset>

			<div class='ddc-form-check ddc-form-check-terms'>
				<label>
					<input type='checkbox' name='terms' value='1' required>
					<span>I accept the Terms and Privacy Policy</span>
				</label>
			</div>

			<div class='ddc-input-group-action ddc-form-actions ddc-mg-0'>
				<label>
					<span class='ddc-form-label-placeholder'>Email address</span>
					<input type='email' name='email' placeholder='Email address' autocomplete='email' required>
				</label>
				<button type='submit' class='ddc-btn' data-submit-loading>Subscribe</button>
			</div>

			<div class="ddc-form-hint-error form-validation-invalid">
				Select one or more newsletters to continue.
			</div>
			<div  class='g-recaptcha' data-sitekey='6Ld-iSYTAAAAAOO0VTEwVl71HtvrFoSlPSibGr4g' data-callback='DDC_RECAPTCHA_CALLBACK' data-size='invisible'></div>		</form>
	</div>
</div>
</div>
<!-- Sidebar end -->
</main>

<footer id='footer' class='ddc-footer' data-google-interstitial='false'>
	<div class='ddc-width-container'>
		<div class='ddc-footer-promo-wrap'>
			<div class='ddc-footer-promo-content'>
				<b>Drugs.com Mobile App</b>
				<p class='ddc-mgt-0 ddc-mgb-2'>Access drug &amp; treatment information, identify pills, check interactions and set up personal medication records.</p>
				<div class='ddc-flex ddc-flex-wrap ddc-flex-gap-4'>
					<a href='//apps.apple.com/us/app/drugs-com-medication-guide/id599471042?platform=iphone' target='_blank' rel='noopener noreferrer'>
						<span class='ddc-sr-only'>Download the Medication Guide app on iTunes</span>
						<img src='/img/v-20250930/apps/apple-store.png' loading='lazy' width='132' height='44' alt='' aria-hidden='true'>
					</a>
					<a href='//play.google.com/store/apps/details?id=com.drugscom.app' target='_blank' rel='noopener noreferrer'>
						<span class='ddc-sr-only'>Download the Medication Guide app on the Google Play store</span>
						<img src='/img/v-20250930/apps/google-play.png' loading='lazy' width='149' height='44' alt='' aria-hidden='true'>
					</a>
				</div>
			</div>

			<div class='ddc-footer-promo-image'>
				<picture>
					<source srcset='/img/v-20250709/apps/promo-uberapp-large.png' media='(min-width: 768px)'>
					<img src='/img/v-20250709/apps/promo-uberapp.png' width='334' height='252' loading='lazy' alt='Drugs.com mobile app'>
				</picture>
			</div>
		</div>

		<nav class='ddc-footer-navigation' aria-label='Informational and social site links'>
			<div class='ddc-footer-column-logo'>
				<a href='/'>
					<span class='ddc-sr-only'>Drugs.com</span>
					<img src='/img/logo/drugscom-logo-mark.svg' loading='lazy' alt='' aria-hidden='true'>
				</a>
			</div>

			<div class='ddc-footer-column ddc-flex ddc-flex-column ddc-flex-gap-4'>
				<b class='ddc-footer-column-title'>About</b>
				<ul class='ddc-flex ddc-flex-column ddc-flex-gap-2 ddc-list-unstyled ddc-mg-0 ddc-text-size-small'>
					<li><a href='/support/about.html'>About Drugs.com</a></li>
					<li><a href='/support/advertising.html'>Advertising policy</a></li>
					<li><a href='/support/citations.html'>Attribution &amp; citations</a></li>
				</ul>
			</div>

			<div class='ddc-footer-column ddc-flex ddc-flex-column ddc-flex-gap-4'>
				<b class='ddc-footer-column-title'>Terms &amp; privacy</b>
				<ul class='ddc-flex ddc-flex-column ddc-flex-gap-2 ddc-list-unstyled ddc-mg-0 ddc-text-size-small'>
					<li><a href='/support/terms.html'>Terms of use</a></li>
					<li><a href='/support/editorial_policy.html'>Editorial policy</a></li>
					<li><a href='/support/privacy.html'>Privacy policy</a>
											</li>
									</ul>
			</div>

			<div class='ddc-footer-column ddc-flex ddc-flex-column ddc-flex-gap-4'>
				<b class='ddc-footer-column-title'>Support</b>
				<ul class='ddc-flex ddc-flex-column ddc-flex-gap-2 ddc-list-unstyled ddc-mg-0 ddc-text-size-small'>
					<li><a href='/support/'>Help center</a></li>
					<li><a href='/sitemap.html'>Sitemap</a></li>
					<li><a href='/support/contact.html'>Contact us</a></li>
					<li><a href='/support/accessibility.html'>Accessibility</a></li>
				</ul>
			</div>

			<div class='ddc-footer-column-social ddc-flex ddc-flex-column ddc-flex-gap-4'>
									<ul class='ddc-flex ddc-flex-wrap ddc-flex-gap-4 ddc-list-unstyled ddc-mg-0'>
						<li>
							<a href='/newsletters/'>
								<span class='ddc-sr-only'>Subscribe to Drugs.com newsletters</span>
								<svg class='ddc-icon ddc-icon-emailfilled' width='24' height='24' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M20.5 4.5h-17a2 2 0 0 0-2 2v11a2 2 0 0 0 2 2h17a2 2 0 0 0 2-2v-11a2 2 0 0 0-2-2Zm-.57 2.864-7.5 5.25a.75.75 0 0 1-.86 0l-7.5-5.25a.75.75 0 1 1 .86-1.228v-.001l7.07 4.95 7.07-4.949a.75.75 0 0 1 .86 1.228Z' /></svg>							</a>
						</li>
						<li>
							<a href='//www.facebook.com/Drugscom' target='_blank' rel='noopener noreferrer'>
								<span class='ddc-sr-only'>Follow Drugs.com on Facebook</span>
								<svg class='ddc-icon ddc-icon-facebook' width='24' height='24' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M14 6.54c-2.06 0-3.4 1.25-3.4 3.52v2H8.3v2.61h2.3V21A9.04 9.04 0 013 12.05C3 7.05 7.03 3 12 3s9 4.05 9 9.05c0 4.53-3.3 8.27-7.6 8.95v-6.33h2.1l.4-2.62h-2.5v-1.7c0-.7.35-1.4 1.47-1.4h1.14V6.7s-1.03-.17-2.02-.17z' /></svg>							</a>
						</li>
						<li>
							<a href='//twitter.com/drugscom' target='_blank' rel='noopener noreferrer'>
								<span class='ddc-sr-only'>Follow Drugs.com on X (Twitter)</span>
								<svg class='ddc-icon ddc-icon-twitter' width='24' height='24' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M13.6935 10.614L20.382 3H18.7972L12.987 9.60975L8.34975 3H3L10.014 12.996L3 20.9797H4.58475L10.7167 13.998L15.615 20.9797H20.9647L13.6935 10.614ZM11.5222 13.0837L10.8105 12.0877L5.15625 4.17H7.59075L12.1552 10.5623L12.864 11.5583L18.7965 19.8668H16.362L11.5222 13.0837Z' /></svg>							</a>
						</li>
						<li>
							<a href='//www.instagram.com/drugs.com_official/' target='_blank' rel='noopener noreferrer'>
								<span class='ddc-sr-only'>Follow Drugs.com on Instagram</span>
								<svg class='ddc-icon ddc-icon-instagram' width='24' height='24' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M11.953 3h.094l4.147.121c1.098.124 1.994.382 2.752.964.364.28.69.605.97.969.58.758.84 1.654.963 2.752C21 8.88 21 10.234 21 11.953v.094l-.121 4.147c-.124 1.098-.382 1.994-.964 2.752a5.25 5.25 0 0 1-.969.97c-.758.58-1.654.84-2.752.963C15.12 21 13.766 21 12.047 21h-.094c-1.72 0-3.074 0-4.147-.121-1.098-.124-1.994-.382-2.752-.964a5.25 5.25 0 0 1-.97-.969c-.58-.758-.84-1.654-.963-2.752C3 15.12 3 13.766 3 12.047v-.094l.121-4.147c.124-1.098.382-1.994.964-2.752.28-.364.605-.69.969-.97.758-.58 1.654-.84 2.752-.963C8.88 3 10.234 3 11.953 3zM7.974 4.612c-.964.108-1.553.315-2.007.663-.26.2-.493.432-.692.692-.348.454-.555 1.043-.663 2.007-.11.98-.112 2.25-.112 4.026l.112 4.026c.108.964.315 1.553.663 2.007.2.26.432.493.692.692.454.348 1.043.555 2.007.663.98.11 2.25.112 4.026.112l4.026-.111c.964-.11 1.553-.316 2.007-.664.26-.2.493-.432.692-.692.348-.454.555-1.043.663-2.007.11-.98.112-2.25.112-4.026l-.111-4.026c-.11-.964-.316-1.553-.664-2.007a3.75 3.75 0 0 0-.692-.692c-.454-.348-1.043-.555-2.007-.663-.98-.11-2.25-.112-4.026-.112l-4.026.112zM12 9a3 3 0 1 0 0 6 3 3 0 0 0 0-6zm-4.5 3a4.5 4.5 0 1 1 9 0 4.5 4.5 0 0 1-9 0zm9.375-3.75a1.125 1.125 0 1 0 0-2.25 1.125 1.125 0 0 0 0 2.25z' /></svg>							</a>
						</li>
						<li>
							<a href='//www.youtube.com/user/drugscom' target='_blank' rel='noopener noreferrer'>
								<span class='ddc-sr-only'>Follow Drugs.com on YouTube</span>
								<svg class='ddc-icon ddc-icon-youtube' width='24' height='24' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M12.25 5c.57 0 2.05.01 3.58.07l.5.01c1.45.06 2.85.16 3.48.32.86.22 1.54.86 1.77 1.68.38 1.33.42 3.96.42 4.5v.18c0 .53-.04 3.16-.42 4.5-.23.81-.9 1.46-1.77 1.68-1.33.34-6.12.39-7.46.4h-.71c-1.33-.01-6.12-.06-7.45-.4a2.45 2.45 0 01-1.77-1.69A22.62 22.62 0 012 11.76v-.19c0-.53.04-3.16.42-4.49.23-.82.9-1.46 1.77-1.68.63-.16 2.03-.26 3.47-.32l.51-.01C9.7 5 11.18 5 11.75 5zm-2.3 3.85v5.63l5.23-2.81-5.23-2.82z' /></svg>							</a>
						</li>
						<li>
							<a href='//www.pinterest.com/drugscom/' target='_blank' rel='noopener noreferrer'>
								<span class='ddc-sr-only'>Follow Drugs.com on Pinterest</span>
								<svg class='ddc-icon ddc-icon-pinterest' width='24' height='24' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M11.97 3a9 9 0 00-3.29 17.36 8.48 8.48 0 010-2.57l1.06-4.5c-.16-.41-.25-.85-.24-1.29 0-1.25.73-2.19 1.63-2.19a1.14 1.14 0 011.14 1.29c0 .77-.49 1.93-.75 3a1.28 1.28 0 001.35 1.62c1.6 0 2.83-1.69 2.83-4.12a3.55 3.55 0 00-3.77-3.66 3.92 3.92 0 00-4.08 3.9c0 .74.22 1.46.65 2.06.06.07.09.16.06.25l-.25 1.03c-.02.12-.13.2-.3.12-1.13-.53-1.83-2.17-1.83-3.5 0-2.83 2.07-5.44 5.96-5.44 3.13 0 5.57 2.23 5.57 5.2 0 3.1-1.93 5.6-4.69 5.6-.82.02-1.6-.36-2.07-1.03l-.56 2.14a9.98 9.98 0 01-1.12 2.36c.87.25 1.79.38 2.7.37A9.02 9.02 0 0021 12c0-4.97-4.04-9-9.03-9' /></svg>							</a>
						</li>
					</ul>
									<p class='ddc-mg-0 ddc-text-size-small'><a href='/newsletters/'><u>Subscribe to our newsletter</u></a> for the latest medication news, new drug approvals and FDA alerts.</p>
			</div>
		</nav>

		<div class='ddc-footer-description ddc-text-color-secondary ddc-text-size-small'>
			<strong>Drugs.com</strong> provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex (updated Nov 2, 2025), Cerner Multum&trade; (updated Dec 5, 2025), ASHP (updated Nov 10, 2025) and others.
		</div>

		<div class='ddc-footer-details ddc-flex ddc-flex-gap-5'>
			<div class='ddc-footer-badges ddc-flex ddc-flex-justify-center ddc-flex-wrap'>
									<a class='ddc-flex-shrink-0' href='//privacy.truste.com/privacy-seal/validation?rid=d18cba4a-afc4-4863-af81-8262bb120271' target='_blank' rel='noopener noreferrer'>
						<img src='//privacy-policy.truste.com/privacy-seal/seal?rid=d18cba4a-afc4-4863-af81-8262bb120271' loading='lazy' width='142' height='45' alt='Certified by TRUSTe'>
					</a>
									<img class='ddc-flex-shrink-0' src='/img/v-20240725/logo/vendor/tag-verified.png' loading='lazy' width='47' height='45' alt='Verified by TAG'>

				<a class='ddc-flex-shrink-0' href='//aacihealthcare.com/certificates/c173-2022-trust-usa/' target='_blank' rel='noopener noreferrer'>
					<img src='/img/v-20251028/logo/vendor/trust-mark-logo.png' loading='lazy' width='91' height='45' alt='This website is certified by AACI. Click to verify.'>
				</a>

				<a class='ddc-flex-shrink-0' href='/support/privacy/advertising.html'>
					<img src='/img/v-20240725/logo/vendor/adchoices-logomark.png' loading='lazy' width='120' height='45' alt='AdChoices - Ad privacy information'>
				</a>
			</div>

			<div class='ddc-footer-copyright ddc-text-color-secondary ddc-text-size-small'>
				Copyright &copy; 2000-2025 Drugs.com. <span class='ddc-text-nowrap'>All rights reserved.</span>
			</div>
		</div>
	</div>
</footer>
<div class='ddc-social-share'></div>

<script>
window.SITETIMING = Date.now();
window.SITECONFIG = {"agent":{"isMobile":false},"user":{"userid":0,"consent":{"reloadPage":false,"region":{"ccpa":true,"gdpr":false},"cookie":{"storeData":"ddc-gdpr-sd","trackAds":"ddc-gdpr-ta","trackContent":"ddc-gdpr-tc","optOut":"ddc-ccpa-oo"}}},"page":{"section":"history","subsection":"","doc":"content","delayedScripts":[{"url":"//www.googletagmanager.com/gtm.js?id=GTM-MZ4MM39"},{"url":"//sb.scorecardresearch.com/cs/38584006/beacon.js"},{"url":"//aim-tag.hcn.health/js/client.js?dl=aimDataLayer"},{"url":"//dmp.tapnative.com/adx-tag-manager/container?id=acc8e0099f27c247fddec729bf747b30&adx_custom=fid:0"}],"pdt":0,"image":{"lazyLoad":{"screens":0.2,"delay":2000}}},"dwLog":{"a":"4084","b":"19183","c":"7,514,1419,641,10586,10657,1121,58,115","d":"127,9","e":"182","f":1215,"h":0,"i":"default","k":"58","l":"","m":"","n":"","o":"","p":0,"q":"history","s":[]},"drugs":[{"ddc_id":4084,"brand_name_id":19183,"mtm_id":"d09350","generic_name":"upadacitinib systemic","name":"Rinvoq"}],"options":{"classifyLists":{"wrapper":"#content","countHtmlItems":false,"numItems":{"short":15,"medium":30,"long":60},"charLimit":{"paragraph":30,"content":350}}},"feedback":{"url":"/history/rinvoq.html","section":"history","doc":"content","referrer":"","css":"/bundle/css/component/component-feedback.min.8680587e.css","target":"#more-resources","triggers":["#more-resources","#footer"]},"modal":null,"subscribe":null,"ads":{"section":"history","ugc":false,"uvc":{"name":"Rinvoq","ddc_id":4084,"brand_name_id":19183,"type":"forecast"},"isPro":false,"aim":{"apiKey":"aaef72dc-3586-472b-b5e6-bca780bd6a4e"},"fixable":{"leaderboard":[{"height":250,"duration":7000},{"height":90,"duration":11000},{"height":0,"duration":15000}]},"refresh":{"divIds":["display-ad-1","display-ad-sidebar-"],"maxRefreshCount":5,"minViewArea":75,"minSinceLoad":30000,"minSinceLoadAdx":30000,"minSinceImpression":5000,"minSinceFocus":5000},"interstitial":null,"display":{"confiant":false,"mobile":false,"timeout":750,"sectionPrivacy":"/7146/DDC_PRV","targeting":{"p":0,"ugc":0,"rc":0,"d":4084,"b":19183,"c1":[1834,1738],"c2":[58],"c2o":[58],"dc":[],"ut":["db43f0","b6fe9a","13fec2","3eb787","128f31"],"rx":1,"pdt":0},"units":[{"id":"display-ad-1","section":"/7146/history","sizes":[[728,90]],"sizeMappings":[[[0,0],[]],[[320,300],[[320,50],[300,50]]],[[750,300],[[728,90]]]],"targeting":{"uid":"d-leaderboard-1","location":"leaderboard","mobile":0,"prebid":1,"size":"728x90"},"prebid":1},{"id":"display-ad-2","section":"/7146/history","sizes":[[300,250]],"sizeMappings":[[[0,0],[]],[[600,440],[[300,250]]]],"targeting":{"uid":"d-mrec-1","location":"mrec","mobile":0,"prebid":1,"size":"300x250"},"prebid":1}]},"injection":{"maximum":{"ads":15,"tags":500},"container":"[data-ad-injection]","start":["h1"],"insert":["h2","h3","h4","p","ol","ul",".ddc-box",".ddc-media",".responsive-table-wrap"],"blacklist":["blockquote","form","ol","ul","dl","table",".blackboxWarning",".ddc-accordion",".ddc-accordion-wrap",".ddc-box",".ddc-card",".ddc-expand-read-more",".ddc-form-inline",".ddc-grid",".ddc-injection-ignore-inside",".ddc-legend",".ddc-media",".ddc-notification",".ddc-paging",".ddc-reference-list",".responsive-table-wrap",".referenceList"],"list":[{"type":"Prebid","lazy":0.14,"displayOptions":0,"buffer":-1,"viewportPercent":150,"format":"content","section":"/7146/history","sizes":[[728,90]],"sizeMappings":[[[0,0],[]],[[320,440],[[300,250]]],[[360,600],[[336,280],[300,250]]],[[1120,300],[[728,90]]]],"targeting":{"uid":"d-728x90-auto-1","location":"content","mobile":0,"prebid":1,"size":"728x90"},"prebid":1},{"type":"Prebid","lazy":0.14,"displayOptions":0,"buffer":1100,"format":"content","section":"/7146/history","sizes":[[728,90]],"sizeMappings":[[[0,0],[]],[[320,440],[[300,250]]],[[360,600],[[336,280],[300,250]]],[[1120,300],[[728,90]]]],"targeting":{"uid":"d-728x90-auto-2","location":"content","mobile":0,"prebid":1,"size":"728x90"},"prebid":1},{"type":"Prebid","lazy":0.14,"displayOptions":0,"buffer":1100,"format":"content","section":"/7146/history","sizes":[[728,90]],"sizeMappings":[[[0,0],[]],[[320,440],[[300,250]]],[[360,600],[[336,280],[300,250]]],[[1120,300],[[728,90]]]],"targeting":{"uid":"d-728x90-auto-3","location":"content","mobile":0,"prebid":1,"size":"728x90"},"prebid":1}],"repeat":{"type":"Prebid","lazy":0.14,"displayOptions":0,"buffer":1100,"format":"content","section":"/7146/history","sizes":[[728,90]],"sizeMappings":[[[0,0],[]],[[320,440],[[300,250]]],[[360,600],[[336,280],[300,250]]],[[1120,300],[[728,90]]]],"targeting":{"uid":"d-728x90-auto-4","location":"content","mobile":0,"prebid":1,"size":"728x90"},"prebid":1}},"sidebar":{"max":10,"ad300x250":{"type":"Prebid","lazy":0.14,"displayOptions":2,"format":"300x250","width":"300","height":"250","section":"/7146/history","sizes":[[300,250]],"sizeMappings":[[[0,0],[]],[[600,440],[[300,250]]]],"targeting":{"uid":"d-300x250-static-1","location":"sidebar","mobile":0,"prebid":1,"size":"300x250"},"prebid":1},"ad300x600":{"type":"Prebid","lazy":0.14,"displayOptions":2,"format":"300x600","width":"300","height":"600","section":"/7146/history","sizes":[[300,250],[300,600]],"sizeMappings":[[[0,0],[]],[[600,440],[[300,250]]],[[600,900],[[300,600],[300,250]]]],"targeting":{"uid":"d-300x600-static-1","location":"sidebar","mobile":0,"prebid":1,"size":"300x600"},"prebid":1},"ad300x600Positions":[1,3,5]}},"nativeApp":null,"interaction":{"isDeferredSave":false,"url":"/interaction/list/","param":{"drugList":"drug_list","listId":"interaction_list_id"}}};
</script>

<script src='//securepubads.g.doubleclick.net/tag/js/gpt.js' async></script>
<script type='application/deferred' data-src='//micro.rubiconproject.com/prebid/dynamic/13482.js'></script>
<script type='application/deferred' data-src='//cdn.confiant-integrations.net/UEWeDkhzdHOmsrWhvv4ZBOs8vy4/gpt_and_prebid/config.js'></script>
<script data-platId='1' data-pubId='23' data-siteId='186' type='application/deferred' data-src='//servedbydoceree.doceree.com/resources/p/doc_ad/23/186/dc.js'></script>
<script src='/bundle/5c5bac4f/js/module/main-primary.js' type='module'></script>
<script src='/bundle/5c5bac4f/js/module/main-secondary.js' type='module'></script>
<script src='/bundle/js/polyfill.min.d0f60cac.js' nomodule defer></script>
<script src='/bundle/js/polyfill/promise/polyfill.min.61fc9c0d.js' nomodule defer></script>
<script src='/bundle/js/polyfill/fetch/fetch.umd.min.fae84870.js' nomodule defer></script>
<script src='/bundle/js/polyfill/intersection-observer/IntersectionObserver.min.48c80c7c.js' nomodule defer></script>
<script src='/bundle/js/rollup.min.5c5bac4f.js' nomodule defer></script>
<script>
window.dataLayer = window.dataLayer || [];
window.dataLayer.push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
window.dataLayer.push({"event":"pageview","drug_name":"Rinvoq","drug_id":"4084-19183","ddc_id":"4084","brand_name_id":"19183","condition_ids":";58;","zone_ids":";1834;1738;","user_signed_in":"No","user_ilink":"No","page_index_status":"index/follow","page_orphan":"No","page_traffic_op":"No","content_type":"Drug","content_section":"News","content_sub_section":"Drug Approval History","content_audience":"Consumer","content_language":"English","content_size":"Medium Page","content_ugc":"No","app_source":"Web","ads_pro":"No","content_reviewer":"Judith Stewart","content_last_updated":"2025-10-16"});
</script>
<script>
window._comscore = window._comscore || [];
window._comscore.push({c1: '2', c2: '38584006', cs_ucfr: '1', options: {enableFirstPartyCookie: true, bypassUserConsentRequirementFor1PCookie: false}});
</script>

<!-- 2025-12-09T01:47:51+00:00 -->

</body>
</html>
